CHAPEL HILL, N.C., Feb. 7 /PRNewswire/ -- Selecting and deploying cross- functional, yet sufficiently specialized, brand teams is a new challenge for marketing leaders at pharmas and biotechs. However, best-in-class pharma and biotech firms' brand teams share similar structure, composition, and responsibilities -- all detailed in a new benchmarking report by pharmaceutical research leader Best Practices, LLC.
According to research findings, most brands have a core team of three to 10 people and 86 percent of the pharma and biotech companies reported that the brand team leader sits in the marketing function.
The study, "Best Practices in Designing Effective Brand Teams: Brand Governance and Brand Team Management," yields insights into key benchmarks and strategies for designing effective brand teams. Managers and executives involved with brand teams can use this report to assess their teams and compare structure and governance styles of leading pharmaceutical and biotech brand teams.
A complimentary excerpt of the research report with sample key findings and metrics is reserved for you at http://www3.best-in-class.com/rr908.htm.
The study includes insights gleaned from survey results from brand team
managers and executives representing 22 brands in 26 different companies.
Deep-dive interviews to flesh out best practices were conducted with 10
managers from the benchmark partners, which included Abbott, Amylin, Bayer,
Genentech, GSK, Roche, Novartis and Wyeth.
The comprehensive report reveals findings around key topics, including:
-- Staffing and functional representation for brand teams
-- Brand team operations, decision rights and responsibilities
-- Reporting relationships
-- Performance-based compensation and reviews
-- Brand performance measures
For a detailed report overview and sample metrics, download the report
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved